NCT00035087View on ClinicalTrials.gov

EPO906 Therapy in Patients With Advanced Colorectal Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

May 31, 2002

Primary Completion Date

March 31, 2003

Study Completion Date

March 31, 2003

Conditions
Colorectal NeoplasmsColonic Neoplasms
Interventions
DRUG

epothilone b

Trial Locations (1)

08901

Cancer Institute of New Jersey (CINJ), New Brunswick

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY